Literature DB >> 11159191

PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification.

F Rutsch1, S Vaingankar, K Johnson, I Goldfine, B Maddux, P Schauerte, H Kalhoff, K Sano, W A Boisvert, A Superti-Furga, R Terkeltaub.   

Abstract

Inogranic pyrophosphate (PPi) inhibits hydroxyapatite deposition, and mice deficient in the PPi-generating nucleoside triphosphate pyrophosphohydrolase (NTPPPH) Plasma cell membrane glycoprotein-1 (PC-1) develop peri-articular and arterial calcification in early life. In idiopathic infantile arterial calcification (IIAC), hydroxyapatite deposition and smooth muscle cell (SMC) proliferation occur, sometimes associated with peri-articular calcification. Thus, we assessed PC-1 expression and PPi metabolism in a 25-month-old boy with IIAC and peri-articular calcifications. Plasma PC-1 was <1 ng/ml by enzyme-linked immunosorbent assay in the proband, but 10 to 30 ng/ml in unaffected family members and controls. PC-1 functioned to raise extracellular PPi in cultured aortic SMCs. However, PC-1 was sparse in temporal artery lesion SMCs in the proband, unlike the case for SMCs in atherosclerotic carotid artery lesions of unrelated adults. Proband plasma and explant-cultured dermal fibroblast NTPPPH and PPi were markedly decreased. The proband was heterozygous at the PC-1 locus, and sizes of PC-1 mRNA and polypeptide, and the PC-1 mRNA-coding region sequence were normal in proband fibroblasts. However, immunoreactive PC-1 protein was relatively sparse in proband fibroblasts. In conclusion, deficient extracellular PPi and a deficiency of PC-1 NTPPPH activity can be associated with human infantile arterial and peri-articular calcification, and may help explain the sharing of certain phenotypic features between some IIAC patients and PC-1-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159191      PMCID: PMC1850320          DOI: 10.1016/S0002-9440(10)63996-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification.

Authors:  F Rutsch; P Schauerte; H Kalhoff; M Petrarulo; C August; L Diekmann
Journal:  Acta Paediatr       Date:  2000-10       Impact factor: 2.299

Review 2.  Tech.sight. Genetic testing--present and future.

Authors:  H Yan; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2000-09-15       Impact factor: 47.728

3.  Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL).

Authors:  I Nakamura; S Ikegawa; A Okawa; S Okuda; Y Koshizuka; H Kawaguchi; K Nakamura; T Koyama; S Goto; J Toguchida; M Matsushita; T Ochi; K Takaoka; Y Nakamura
Journal:  Hum Genet       Date:  1999-06       Impact factor: 4.132

4.  Idiopathic infantile arterial calcification: a case report and review of the literature.

Authors:  C Maayan; O Peleg; F Eyal; P Mogle; E Rosenmann; J Bar Ziv
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

5.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

6.  Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1.

Authors:  K A Johnson; L Hessle; S Vaingankar; C Wennberg; S Mauro; S Narisawa; J W Goding; K Sano; J L Millan; R Terkeltaub
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

Review 7.  Natural history of calcium deposits in atherosclerosis progression and regression.

Authors:  H C Stary
Journal:  Z Kardiol       Date:  2000

8.  Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes.

Authors:  K Johnson; S Vaingankar; Y Chen; A Moffa; M B Goldring; K Sano; P Jin-Hua; A Sali; J Goding; R Terkeltaub
Journal:  Arthritis Rheum       Date:  1999-09

9.  Idiopathic infantile arterial calcification with cardiac, renal and central nervous system involvement.

Authors:  M Van Dyck; W Proesmans; E Van Hollebeke; G Marchal; P Moerman
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

Review 10.  Ecto-enzymes: physiology meets pathology.

Authors:  J W Goding
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

View more
  103 in total

Review 1.  The bone-vascular axis in chronic kidney disease.

Authors:  Linda Demer; Yin Tintut
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

2.  Generalized arterial calcification of infancy: two siblings with prolonged survival.

Authors:  Giovanni Ciana; Antonella Trappan; Bruno Bembi; Alessandra Benettoni; Giampaolo Maso; Floriana Zennaro; Nico Ruf; Dirk Schnabel; Frank Rutsch
Journal:  Eur J Pediatr       Date:  2005-11-29       Impact factor: 3.183

3.  Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up.

Authors:  Inge M van der Sluis; Annemieke M Boot; Meike Vernooij; Morteza Meradji; André A Kroon
Journal:  Eur J Pediatr       Date:  2006-04-29       Impact factor: 3.183

4.  Idiopathic infantile arterial calcification: imaging evaluation and the usefulness of MR angiography.

Authors:  Kim H Tran; M Ines Boechat
Journal:  Pediatr Radiol       Date:  2006-01-21

5.  Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.

Authors:  Ricardo Villa-Bellosta; Xiaonan Wang; José Luis Millán; George R Dubyak; W Charles O'Neill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-13       Impact factor: 4.733

6.  Genetic and enzymatic analysis for two Japanese patients with idiopathic infantile arterial calcification.

Authors:  Chikahiko Numakura; Makoto Yamada; Daisuke Ariyasu; Akiko Maesaka; Hironori Kobayashi; Gen Nishimura; Masahiro Ikeda; Yukihiro Hasegawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy.

Authors:  Frank Rutsch; Petra Böyer; Yvonne Nitschke; Nico Ruf; Bettina Lorenz-Depierieux; Tanja Wittkampf; Gabriele Weissen-Plenz; Rudolf-Josef Fischer; Zulf Mughal; John W Gregory; Justin H Davies; Chantal Loirat; Tim M Strom; Dirk Schnabel; Peter Nürnberg; Robert Terkeltaub
Journal:  Circ Cardiovasc Genet       Date:  2008-12

8.  Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia.

Authors:  Domenick A Prosdocimo; Steven C Wyler; Andrea M Romani; W Charles O'Neill; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

9.  Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Authors:  Jonathan M Flanagan; Vivien Sheehan; Heidi Linder; Thad A Howard; Yong-Dong Wang; Carolyn C Hoppe; Banu Aygun; Robert J Adams; Geoffrey A Neale; Russell E Ware
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

10.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.

Authors:  K A Lomashvili; P Garg; S Narisawa; J L Millan; W C O'Neill
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.